The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Starting in 2022, increased demand led to shortages of semaglutide injections sold by Novo Nordisk under the brand names Ozempic ... says the 25-year-old from Texas, and she’s scared to undo ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

The brands Rybelsus ... received 2.4mg injections of semaglutide each week, and they followed a 16-week dose escalation schedule. All participants were at least 18 years old and had ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

WeightWatchers has turned its back on its traditional business model and has caved to peddling the weight loss drugs that ...

The celebrated actress has lost more than 100Ib after turning to controversial diabetes jab Ozempic - now better known for its impact on tackling obesity ...